Find us on...
On 29 December 2022, US President Joe Biden signed into law the Consolidated Appropriations Act of 2023, which includes the Modernisation of Cosmetics Regulation Act of 2022 (MOCRA) in Subtitle E – Cosmetics. The amendments to the Federal Food, Drug and Cosmetic (FD&C) Act will take effect one year after the enactment date of the MOCRA, that is on 29 December 2023.
MOCRA will require cosmetics sold in the US to comply with several new requirements, such as serious adverse events reporting, Good Manufacturing Practices (GMPs), and mandatory facility registration and product listing.
The key requirements are summarised as below:
New Concept |
Requirement |
Responsible Person (RP) |
RP means the manufacturer, packer, or distributor of a cosmetic product whose name appears on the label of such cosmetic product |
Facility Registration |
|
Mandatory Product Listing |
|
Serious Adverse Event Reporting |
|
Mandatory Recall |
FDA may order a recall if an RP refuses to or does not voluntarily cease distribution or recall a cosmetic within the time and manner requested. |
Additional Labelling Requirements |
|
In addition, MOCRA requests FDA to work on:
- Establishing standardised testing methods for detecting and identifying asbestos in talc-containing cosmetic products within the next one year and 180 days;
- Publishing a rulemaking on fragrance allergens labelling within the next two years;
- Issuing new regulations to establish GMP requirements for facilities within the next three years;
- Assessing the use of perfluoroalkyl and polyfluoroalkyl substances (PFAS) in cosmetic products and publish a report summarising the results within the next three years.
For further details, please visit FDA's dedicated page on MoCRA.